Prothena Corp Files 8-K: Security Holder Vote & Exhibits
Ticker: PRTA · Form: 8-K · Filed: Nov 19, 2025 · CIK: 1559053
| Field | Detail |
|---|---|
| Company | Prothena Corp Public Ltd Co (PRTA) |
| Form Type | 8-K |
| Filed Date | Nov 19, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, financial-reporting, shareholder-vote
Related Tickers: PRTA
TL;DR
Prothena filed an 8-K today for a shareholder vote and financial docs. Stay tuned.
AI Summary
On November 19, 2025, Prothena Corporation plc filed an 8-K report. The filing indicates that the company is submitting matters to a vote of its security holders and is also filing financial statements and exhibits. No specific details regarding the nature of the vote or the content of the financial statements and exhibits were provided in this excerpt.
Why It Matters
This filing signals important corporate actions, including a vote by shareholders and the submission of financial documents, which could impact investor decisions and regulatory oversight.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for corporate governance and financial reporting, not indicating any immediate operational or financial distress.
Key Players & Entities
- Prothena Corporation plc (company) — Registrant
- November 19, 2025 (date) — Date of earliest event reported
FAQ
What is the specific purpose of the submission of matters to a vote of security holders?
The provided excerpt does not specify the exact nature or purpose of the matters being submitted for a vote by security holders.
What financial statements and exhibits are being filed with this 8-K?
The excerpt states that financial statements and exhibits are being filed, but does not detail their content or nature.
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is November 19, 2025.
Under which section of the Securities Exchange Act of 1934 is this 8-K report filed?
This 8-K report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is Prothena Corporation plc's jurisdiction of incorporation?
Prothena Corporation plc is incorporated in Ireland.
Filing Stats: 492 words · 2 min read · ~2 pages · Grade level 12 · Accepted 2025-11-19 16:30:57
Key Financial Figures
- $0.01 — Registered Ordinary Shares, par value $0.01 per share PRTA The Nasdaq Global Select
Filing Documents
- prta-20251119.htm (8-K) — 32KB
- 0001559053-25-000047.txt ( ) — 151KB
- prta-20251119.xsd (EX-101.SCH) — 2KB
- prta-20251119_lab.xml (EX-101.LAB) — 23KB
- prta-20251119_pre.xml (EX-101.PRE) — 13KB
- prta-20251119_htm.xml (XML) — 3KB
07. Submission of Matters to a Vote of Security Holders
Item 5.07. Submission of Matters to a Vote of Security Holders. On November 19, 2025, Prothena Corporation plc (the "Company") held an extraordinary general meeting of shareholders, at which the Company's shareholders voted on the following proposal, which is described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on October 7, 2025: Proposal No. 1: Approval of a Reduction of the Company's Capital to Create Distributable Reserves. The shareholders approved a reduction of the Company's capital to create distributable reserves. For Against Abstain 37,779,052 46,738 45,906
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 19, 2025 PROTHENA CORPORATION PLC By: /s/ Tran B. Nguyen Name: Tran B. Nguyen Title: Chief Strategy Officer and Chief Financial Officer